Status:
COMPLETED
Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection.
Lead Sponsor:
Hospital Clinic of Barcelona
Conditions:
Post ICU Syndrome
Chronic Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
COVID-19 (coronavirus 2019) disease has led to a large number of hospital admissions, many of which require admission to intensive care (ICU). Post-intensive care syndrome (PICS) is defined as deteri...
Detailed Description
A randomized, controlled, and single-blind trial will be performed. Patients over 18 years who have been admitted to intensive care units with the diagnosis of COVID-19 disease at risk of presenting P...
Eligibility Criteria
Inclusion
- Admitted to the ICU due to COVID infection19.
- APACHE II score\> 14 or ICU stay\> 10 days or Duration of mechanical ventilation\> 7 days or Acquired weakness in ICU or Delirium during ICU admission.
- Accept to participate in the study and sign informed consent.
Exclusion
- Central Nervous System degenerative diseases. Examples: Alzheimer's disease, Amyotrophic lateral sclerosis, Lewy body dementia, Parkinson's disease, among others.
- Terminal illness: Definition according to the palliative care guide, Spanish Society for Palliative Care. "Advanced, progressive, and incurable disease with a lack of reasonable possibilities of specific treatment, with a life prognosis of less than 6 months.
- Insufficient understanding of the Spanish language.
- Patients in whom it would be difficult to complete follow-up.
- Not having informed consent.
Key Trial Info
Start Date :
May 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 22 2021
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT04394169
Start Date
May 25 2020
End Date
October 22 2021
Last Update
December 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tomás Cuñat
Barcelona, Spain, 08036